Common genetic variants in pre-microRNAs are associated with risk of coal workers' pneumoconiosis

Meilin Wang1, Yang Ye, Haiyang Qian

  • 1Department of Occupational Medicine and Environmental Health, Nanjing Medical University, 140 Hanzhong Road, Nanjing, China.

Journal of Human Genetics
|November 3, 2009
PubMed

Insights

Genetic variants in microRNAs (miRNAs) may influence coal workers' pneumoconiosis (CWP) risk. The miR-149 rs2292832 polymorphism was associated with increased CWP susceptibility, particularly in older individuals and those with significant dust exposure.

Area of Science:

  • Genetics
  • Molecular Biology
  • Occupational Health

Background:

  • microRNAs (miRNAs) are small noncoding RNAs regulating gene expression.
  • miRNAs are implicated in various biological processes, including cell proliferation and apoptosis.
  • Genetic variations within miRNAs could impact disease susceptibility.

Purpose of the Study:

  • To investigate the association between single-nucleotide polymorphisms (SNPs) in pre-microRNAs (pre-miRNAs) and the risk of coal workers' pneumoconiosis (CWP).

Main Methods:

  • A case-control study involving 496 CWP patients and 513 controls.
  • Genotyping of four SNPs (rs2910164, rs2292832, rs11614913, rs3746444) in pre-miRNAs (miR-146a, miR-149, miR-196a2, miR-499).
  • Statistical analysis to assess the association between genotypes and CWP risk, including subgroup analyses.

Main Results:

  • The miR-149 rs2292832 TT genotype showed a significantly increased risk of CWP (OR=1.31, 95% CI=1.01-1.69).
  • This increased risk was more pronounced in subgroups: aged > or =68 years, dust exposure > or =26 years, and ever smokers.
  • The miR-149 rs2292832 polymorphism was also associated with CWP stages II and III.

Conclusions:

  • The miR-149 rs2292832 polymorphism is a potential genetic factor contributing to CWP susceptibility.
  • This finding highlights the role of miRNA genetic variants in the pathogenesis of occupational lung diseases.
  • Further research is warranted to elucidate the functional mechanisms underlying this association.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...